<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">28701227</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>09</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1466-609X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Jul</Month>
              <Day>12</Day>
            </PubDate>
          </JournalIssue>
          <Title>Critical care (London, England)</Title>
          <ISOAbbreviation>Crit Care</ISOAbbreviation>
        </Journal>
        <ArticleTitle>High-flow nasal cannula oxygen therapy is superior to conventional oxygen therapy but not to noninvasive mechanical ventilation on intubation rate: a systematic review and meta-analysis.</ArticleTitle>
        <Pagination>
          <StartPage>184</StartPage>
          <MedlinePgn>184</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">184</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-017-1760-8</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND">High-flow nasal cannula oxygen (HFNC) is a relatively new therapy used in adults with respiratory failure. Whether it is superior to conventional oxygen therapy (COT) or to noninvasive mechanical ventilation (NIV) remains unclear. The aim of the present study was to investigate whether HFNC was superior to either COT or NIV in adult acute respiratory failure patients.</AbstractText>
          <AbstractText Label="METHODS">A review of the literature was conducted from the electronic databases from inception up to 20 October 2016. Only randomized clinical trials comparing HFNC with COT or HFNC with NIV were included. The intubation rate was the primary outcome; secondary outcomes included the mechanical ventilation rate, the rate of escalation of respiratory support and mortality.</AbstractText>
          <AbstractText Label="RESULTS">Eleven studies that enrolled 3459 patients (HFNC, n = 1681) were included. There were eight studies comparing HFNC with COT, two comparing HFNC with NIV, and one comparing all three. HFNC was associated with a significant reduction in intubation rate (OR 0.52, 95% CI 0.34 to 0.79, P = 0.002), mechanical ventilation rate (OR 0.56, 95% CI 0.33 to 0.97, P = 0.04) and the rate of escalation of respiratory support (OR 0.45, 95% CI 0.31 to 0.67, P &lt; 0.0001) when compared to COT. There was no difference in mortality between HFNC and COT utilization (OR 1.01, 95% CI 0.67 to 1.53, P = 0.96). When HFNC was compared to NIV, there was no difference in the intubation rate (OR 0.96; 95% CI 0.66 to 1.39, P = 0.84), the rate of escalation of respiratory support (OR 1.00, 95% CI 0.77 to 1.28, P = 0.97) or mortality (OR 0.85, 95% CI 0.43 to 1.68, P = 0.65).</AbstractText>
          <AbstractText Label="CONCLUSIONS">Compared to COT, HFNC reduced the rate of intubation, mechanical ventilation and the escalation of respiratory support. When compared to NIV, HFNC showed no better outcomes. Large-scale randomized controlled trials are necessary to prove our findings.</AbstractText>
          <AbstractText Label="TRIAL REGISTRATION">PROSPERO International prospective register of systematic reviews on May 25, 2016 registration no. CRD42016039581 .</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Huiying</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Critical Care Medicine, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China. zhaohuiying109@sina.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Huixia</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Critical Care Medicine, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Feng</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, 100038, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lyu</LastName>
            <ForeName>Shan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Critical Care Medicine, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>An</LastName>
            <ForeName>Youzhong</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Critical Care Medicine, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China. youzhonganicu@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D017418">Meta-Analysis</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>07</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Crit Care</MedlineTA>
        <NlmUniqueID>9801902</NlmUniqueID>
        <ISSNLinking>1364-8535</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>S88TT14065</RegistryNumber>
          <NameOfSubstance UI="D010100">Oxygen</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentIn">
          <RefSource>Crit Care. 2017 Nov 22;21(1):285</RefSource>
          <PMID Version="1">29166943</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000072601" MajorTopicYN="N">Cannula</DescriptorName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
          <QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName>
          <QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063087" MajorTopicYN="N">Noninvasive Ventilation</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
          <QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Conventional oxygen therapy (COT)</Keyword>
        <Keyword MajorTopicYN="Y">High-flow nasal cannula oxygen (HFNC)</Keyword>
        <Keyword MajorTopicYN="Y">Intubation</Keyword>
        <Keyword MajorTopicYN="Y">Mortality</Keyword>
        <Keyword MajorTopicYN="Y">Noninvasive mechanical ventilation (NIV)</Keyword>
      </KeywordList>
      <CoiStatement>Not applicable. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2016</Year>
          <Month>12</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2017</Year>
          <Month>6</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2017</Year>
          <Month>7</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2017</Year>
          <Month>7</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">28701227</ArticleId>
        <ArticleId IdType="pmc">PMC5508784</ArticleId>
        <ArticleId IdType="doi">10.1186/s13054-017-1760-8</ArticleId>
        <ArticleId IdType="pii">10.1186/s13054-017-1760-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Nishimura M. High-flow nasal cannula oxygen therapy in adults. J Intensive Care. 2015;3:15. doi: 10.1186/s40560-015-0084-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40560-015-0084-5</ArticleId>
            <ArticleId IdType="pmc">PMC4393594</ArticleId>
            <ArticleId IdType="pubmed">25866645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sotello D, Rivas M, Mulkey Z, Nugent K. High-flow nasal cannula oxygen in adult patients: a narrative review. Am J Med Sci. 2015;349:179–85. doi: 10.1097/MAJ.0000000000000345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MAJ.0000000000000345</ArticleId>
            <ArticleId IdType="pubmed">25285514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spoletini G, Alotaibi M, Blasi F, Hill NS. Heated humidified high-flow nasal oxygen in adults: mechanisms of action and clinical implications. Chest. 2015;148:253–61. doi: 10.1378/chest.14-2871.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.14-2871</ArticleId>
            <ArticleId IdType="pubmed">25742321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care. 2016;61:529–41. doi: 10.4187/respcare.04577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4187/respcare.04577</ArticleId>
            <ArticleId IdType="pubmed">27016353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayami H, Mizutani K, Shioda M, Takaki S, Maejima H, et al.  Use of high-flow nasal canulae: effect on alveolar pressure and its limitation. Crit Care. 2013;17(Suppl 2):91. doi: 10.1186/cc12029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/cc12029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parke R, McGuinness S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. Br J Anaesth. 2009;103:886–90. doi: 10.1093/bja/aep280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bja/aep280</ArticleId>
            <ArticleId IdType="pmc">PMC2777940</ArticleId>
            <ArticleId IdType="pubmed">19846404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dysart K, Miller TL, Wolfson MR, Shaffer TH. Research in high flow therapy: mechanisms of action. Respir Med. 2009;103:1400–5. doi: 10.1016/j.rmed.2009.04.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2009.04.007</ArticleId>
            <ArticleId IdType="pubmed">19467849</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wagstaff TA, Soni N. Performance of six types of oxygen delivery devices at varying respiratory rates. Anaesthesia. 2007;62:492–503. doi: 10.1111/j.1365-2044.2007.05026.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2044.2007.05026.x</ArticleId>
            <ArticleId IdType="pubmed">17448063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee JH, Rehder KJ, Williford L, Cheifetz IM, Turner DA. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med. 2013;39:247–57. doi: 10.1007/s00134-012-2743-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00134-012-2743-5</ArticleId>
            <ArticleId IdType="pubmed">23143331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cuquemelle E, Pham T, Papon JF, Louis B, Danin PE, Brochard L. Heated and humidified high-flow oxygen therapy reduces discomfort during hypoxemic respiratory failure. Respir Care. 2012;57:1571–7. doi: 10.4187/respcare.01681.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4187/respcare.01681</ArticleId>
            <ArticleId IdType="pubmed">22417569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itagaki T, Okuda N, Tsunano Y, Kohata H, Nakataki E, Onodera M, et al.  Effect of high-flow nasal cannula on thoraco-abdominal synchrony in adult critically Ill patients. Respir Care. 2014;59:70–4. doi: 10.4187/respcare.02480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4187/respcare.02480</ArticleId>
            <ArticleId IdType="pubmed">23737548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sztrymf B, Messika J, Bertrand F, Hurel D, Leon R, Dreyfuss D, et al.  Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med. 2011;37:1780–6. doi: 10.1007/s00134-011-2354-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00134-011-2354-6</ArticleId>
            <ArticleId IdType="pubmed">21946925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bell N, Hutchinson CL. Randomised control trial of humidified high flow nasal cannulae versus standard oxygen in the emergency department. Emerg Med Australasia. 2015;27:537–41. doi: 10.1111/1742-6723.12490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1742-6723.12490</ArticleId>
            <ArticleId IdType="pubmed">26419650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roca O, Riera J, Torres F, Masclans JR. High-flow oxygen therapy in acute respiratory failure. Respir Care. 2010;55:408–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20406507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rittayamai N, Tscheikuna J, Rujiwit P. High-flow nasal cannula versus conventional oxygen therapy after endotracheal extubation: a randomized crossover physiologic study. Respir Care. 2014;59:485–90. doi: 10.4187/respcare.02397.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4187/respcare.02397</ArticleId>
            <ArticleId IdType="pubmed">24046462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sztrymf B, Messika J, Mayot T, Lenglet H, Dreyfuss D, Ricard JD. Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: A prospective observational study. J Crit Care. 2012;27:324. doi: 10.1016/j.jcrc.2011.07.075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcrc.2011.07.075</ArticleId>
            <ArticleId IdType="pubmed">21958974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lenglet H, Sztrymf B, Leroy C, Brun P, Dreyfuss D, Ricard JD. Humidified high flow nasal oxygen during respiratory failure in the emergency department: feasibility and efficacy. Respir Care. 2012;57:1873–8. doi: 10.4187/respcare.01575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4187/respcare.01575</ArticleId>
            <ArticleId IdType="pubmed">22417844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al.  High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185–96. doi: 10.1056/NEJMoa1503326.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1503326</ArticleId>
            <ArticleId IdType="pubmed">25981908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernandez G, Vaquero C, Gonzalez P, Subira C, Frutos-Vivar F, et al.  Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial. JAMA. 2016;315:1354–61. doi: 10.1001/jama.2016.2711.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2016.2711</ArticleId>
            <ArticleId IdType="pubmed">26975498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones PG, Kamona S, Doran O, Sawtell F, Wilsher M. Randomized controlled trial of humidified high-flow nasal oxygen for acute respiratory distress in the emergency department: the HOT-ER study. Respir Care. 2016;61:291–9. doi: 10.4187/respcare.04252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4187/respcare.04252</ArticleId>
            <ArticleId IdType="pubmed">26577199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maggiore SM, Idone FA, Vaschetto R, Festa R, Cataldo A, Antonicelli F, et al.  Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med. 2014;190:282–8. doi: 10.1164/rccm.201402-0364OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201402-0364OC</ArticleId>
            <ArticleId IdType="pubmed">25003980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parke R, McGuinness S, Dixon R, Jull A. Open-label, phase II study of routine high-flow nasal oxygen therapy in cardiac surgical patients. Br J Anaesth. 2013;111:925–31. doi: 10.1093/bja/aet262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bja/aet262</ArticleId>
            <ArticleId IdType="pubmed">23921199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carron M, Freo U, BaHammam AS, Dellweg D, Guarracino F, Cosentini R, et al.  Complications of non-invasive ventilation techniques: a comprehensive qualitative review of randomized trials. Br J Anaesth. 2013;110:896–914. doi: 10.1093/bja/aet070.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bja/aet070</ArticleId>
            <ArticleId IdType="pubmed">23562934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sferrazza Papa GF, Di Marco F, Akoumianaki E, Brochard L. Recent advances in interfaces for non-invasive ventilation: from bench studies to practical issues. Minerva Anestesiol. 2012;78:1146–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23059519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernandez G, Vaquero C, Colinas L, Cuena R, Gonzalez P, Canabal A, et al.  Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients: a randomized clinical trial. JAMA. 2016;316:1565–74. doi: 10.1001/jama.2016.14194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2016.14194</ArticleId>
            <ArticleId IdType="pubmed">27706464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monro-Somerville T, Sim M, Ruddy J, Vilas M, Gillies MA. The effect of high-flow nasal cannula oxygen therapy on mortality and intubation rate in acute respiratory failure: a systematic review and meta-analysis. Crit Care Med. 2016;45:e449–56. doi: 10.1097/CCM.0000000000002091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/CCM.0000000000002091</ArticleId>
            <ArticleId IdType="pubmed">27611978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maitra S, Som A, Bhattacharjee S, Arora MK, Baidya DK. Comparison of high-flow nasal oxygen therapy with conventional oxygen therapy and noninvasive ventilation in adult patients with acute hypoxemic respiratory failure: a meta-analysis and systematic review. J Crit Care. 2016;35:138–44. doi: 10.1016/j.jcrc.2016.05.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcrc.2016.05.013</ArticleId>
            <ArticleId IdType="pubmed">27481749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, et al.  Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement. JAMA. 2015;313:1657–65. doi: 10.1001/jama.2015.3656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2015.3656</ArticleId>
            <ArticleId IdType="pubmed">25919529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId>
            <ArticleId IdType="pmc">PMC3196245</ArticleId>
            <ArticleId IdType="pubmed">22008217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34. doi: 10.1136/bmj.315.7109.629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId>
            <ArticleId IdType="pmc">PMC2127453</ArticleId>
            <ArticleId IdType="pubmed">9310563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A, et al.  Going from evidence to recommendations. BMJ. 2008;336:1049–51. doi: 10.1136/bmj.39493.646875.AE.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.39493.646875.AE</ArticleId>
            <ArticleId IdType="pmc">PMC2376019</ArticleId>
            <ArticleId IdType="pubmed">18467413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60. doi: 10.1136/bmj.327.7414.557.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId>
            <ArticleId IdType="pmc">PMC192859</ArticleId>
            <ArticleId IdType="pubmed">12958120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brotfain E, Zlotnik A, Schwartz A, Frenkel A, Koyfman L, Gruenbaum SE, et al.  Comparison of the effectiveness of high flow nasal oxygen cannula versus standard non-rebreather oxygen face mask in post-extubation intensive care unit patients. Isr Med Assoc J. 2014;16:718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25558703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frat JP, Brugiere B, Ragot S, Chatellier D, Veinstein A, Goudet V, et al.  Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study. Respir Care. 2015;60:170–8. doi: 10.4187/respcare.03075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4187/respcare.03075</ArticleId>
            <ArticleId IdType="pubmed">25294935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roca O, de Acilu MG, Caralt B, Sacanell J, Masclans JR, ICU collaborators  Humidified high flow nasal cannula supportive therapy improves outcomes in lung transplant recipients readmitted to the intensive care unit because of acute respiratory failure. Transplantation. 2015;99:1092–8. doi: 10.1097/TP.0000000000000460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/TP.0000000000000460</ArticleId>
            <ArticleId IdType="pubmed">25340596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tiruvoipati R, Lewis D, Haji K, Botha J. High-flow nasal oxygen vs high-flow face mask: a randomized crossover trial in extubated patients. J Crit Care. 2010;25:463–8. doi: 10.1016/j.jcrc.2009.06.050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcrc.2009.06.050</ArticleId>
            <ArticleId IdType="pubmed">19781896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoo JW, Synn A, Huh JW, Hong SB, Koh Y, Lim CM. Clinical efficacy of high-flow nasal cannula compared to noninvasive ventilation in patients with post-extubation respiratory failure. Korean J Intern Med. 2016;31:82–8. doi: 10.3904/kjim.2016.31.1.82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3904/kjim.2016.31.1.82</ArticleId>
            <ArticleId IdType="pmc">PMC4712438</ArticleId>
            <ArticleId IdType="pubmed">26767861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yildirim F. High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. [Turkish] Journal of Medical and Surgical Intensive Care Medicine. 2015;6:60–62.</Citation>
        </Reference>
        <Reference>
          <Citation>Hui D, Morgado M, Chisholm G, Withers L, Nguyen Q, Finch C, et al.  High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial. J Pain Symptom Manage. 2013;46:463–73. doi: 10.1016/j.jpainsymman.2012.10.284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpainsymman.2012.10.284</ArticleId>
            <ArticleId IdType="pmc">PMC3795985</ArticleId>
            <ArticleId IdType="pubmed">23739633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rittayamai N, Tscheikuna J, Praphruetkit N, Kijpinyochai S. Use of high-flow nasal cannula for acute dyspnea and hypoxemia in the emergency department. Respir Care. 2015;60:1377–82. doi: 10.4187/respcare.03837.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4187/respcare.03837</ArticleId>
            <ArticleId IdType="pubmed">26060321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwabbauer N, Berg B, Blumenstock G, Haap M, Hetzel J, Riessen R. Nasal high-flow oxygen therapy in patients with hypoxic respiratory failure: effect on functional and subjective respiratory parameters compared to conventional oxygen therapy and non-invasive ventilation (NIV) BMC Anesthesiol. 2014;14:66. doi: 10.1186/1471-2253-14-66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2253-14-66</ArticleId>
            <ArticleId IdType="pmc">PMC4126617</ArticleId>
            <ArticleId IdType="pubmed">25110463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lucangelo U, Vassallo FG, Marras E, Ferluga M, Beziza E, Comuzzi L, et al.  High-flow nasal interface improves oxygenation in patients undergoing bronchoscopy. Crit Care Res Pract. 2012;2012:506382.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3362832</ArticleId>
            <ArticleId IdType="pubmed">22666567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simon M, Braune S, Frings D, Wiontzek AK, Klose H, Kluge S. High-flow nasal cannula oxygen versus non-invasive ventilation in patients with acute hypoxaemic respiratory failure undergoing flexible bronchoscopy–a prospective randomised trial. Crit Care. 2014;18:712. doi: 10.1186/s13054-014-0712-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13054-014-0712-9</ArticleId>
            <ArticleId IdType="pmc">PMC4300050</ArticleId>
            <ArticleId IdType="pubmed">25529351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corley A, Bull T, Spooner AJ, Barnett AG, Fraser JF. Direct extubation onto high-flow nasal cannulae post-cardiac surgery versus standard treatment in patients with a BMI &gt;/=30: a randomised controlled trial. Intensive Care Med. 2015;41:887–94. doi: 10.1007/s00134-015-3765-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00134-015-3765-6</ArticleId>
            <ArticleId IdType="pubmed">25851385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lemiale V, Mokart D, Mayaux J, Lambert J, Rabbat A, Demoule A, et al.  The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial. Crit Care. 2015;19:380. doi: 10.1186/s13054-015-1097-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13054-015-1097-0</ArticleId>
            <ArticleId IdType="pmc">PMC4629403</ArticleId>
            <ArticleId IdType="pubmed">26521922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parke RL, McGuinness SP, Eccleston ML. A preliminary randomized controlled trial to assess effectiveness of nasal high-flow oxygen in intensive care patients. Respir Care. 2011;56:265–70. doi: 10.4187/respcare.00801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4187/respcare.00801</ArticleId>
            <ArticleId IdType="pubmed">21255498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stephan F, Barrucand B, Petit P, Rézaiguia-Delclaux S, Médard A, Delannoy B, et al.  High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA. 2015;313:2331–9. doi: 10.1001/jama.2015.5213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2015.5213</ArticleId>
            <ArticleId IdType="pubmed">25980660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang BJ, Koh Y, Lim CM, Huh JW, Baek S, Han M, et al.  Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med. 2015;41:623–32. doi: 10.1007/s00134-015-3693-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00134-015-3693-5</ArticleId>
            <ArticleId IdType="pubmed">25691263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindenauer PK, Stefan MS, Shieh MS, Pekow PS, Rothberg MB, Hill NS. Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease. JAMA Intern Med. 2014;174:1982–93. doi: 10.1001/jamainternmed.2014.5430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamainternmed.2014.5430</ArticleId>
            <ArticleId IdType="pmc">PMC4501470</ArticleId>
            <ArticleId IdType="pubmed">25347545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masip J, Roque M, Sanchez B, Fernandez R, Subirana M, Exposito JA. Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. JAMA. 2005;294:3124–30. doi: 10.1001/jama.294.24.3124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.294.24.3124</ArticleId>
            <ArticleId IdType="pubmed">16380593</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
